Literature DB >> 21275960

Re-transplantation after bortezomib-based therapy.

Curly Morris, Gordon Cook, Matthew Streetly, Paul Kettle, Mary Drake, Michael Quinn, Jim Cavet, Jane Tighe, Majit Kazmi, John Ashcroft, Mark Cook, John Snowden, Ade Olujohungbe, Scott Marshall, Jane Conn, Heather Oakervee, Rakesh Popat, Jamie Cavenagh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21275960     DOI： 10.1111/j.1365-2141.2010.08521.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.

Authors:  G Cook
Journal:  Bone Marrow Transplant       Date:  2015-08-03       Impact factor: 5.483

Review 2.  Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity.

Authors:  R F Cornell; A A Kassim
Journal:  Bone Marrow Transplant       Date:  2016-01-04       Impact factor: 5.483

3.  Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.

Authors:  Joanna Drozd-Sokołowska; Luuk Gras; Nienke Zinger; John A Snowden; Mutlu Arat; Grzegorz Basak; Anastasia Pouli; Charles Crawley; Keith M O Wilson; Herve Tilly; Jennifer Byrne; Claude Eric Bulabois; Jakob Passweg; Zubeyde Nur Ozkurt; Wilfried Schroyens; Bruno Lioure; Mercedes Colorado Araujo; Xavier Poiré; Gwendolyn Van Gorkom; Gunhan Gurman; Liesbeth C de Wreede; Patrick J Hayden; Meral Beksac; Stefan O Schönland; Ibrahim Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2022-02-15       Impact factor: 5.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.